- Report
- January 2025
- 182 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- November 2024
- 180 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- March 2025
- 185 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- March 2025
- 185 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- February 2025
- 180 Pages
Global
From €4054EUR$4,500USD£3,577GBP
- Report
- April 2025
- 142 Pages
Global
From €2296EUR$2,549USD£2,026GBP
€2701EUR$2,999USD£2,384GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €901EUR$1,000USD£795GBP
€1126EUR$1,250USD£994GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1441EUR$1,600USD£1,272GBP
€1802EUR$2,000USD£1,590GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1441EUR$1,600USD£1,272GBP
€1802EUR$2,000USD£1,590GBP
- Report
- August 2025
- 220 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- July 2025
- 229 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- May 2025
- 212 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- July 2025
- 246 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- April 2025
- 182 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- March 2025
- 255 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- March 2025
- 212 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- February 2025
- 252 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- February 2025
- 233 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- August 2025
- 150 Pages
Global
From €3024EUR$3,358USD£2,669GBP
€3558EUR$3,950USD£3,140GBP
- Report
- October 2025
- 150 Pages
Global
From €2567EUR$2,850USD£2,265GBP
€3468EUR$3,850USD£3,060GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more